Share

April 05, 2016; 86 (16 Supplement) April 16, 2016

Oligoclonal Immunoglobulin Gamma Bands in the Cerebrospinal Fluid and Risk of Conversion to Secondary Progress in Multiple Sclerosis (P1.370)

Virginija Karrenbauer, Jan Hillert, Ali Manouchehrinia
First published April 4, 2016,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 86 no. 16 Supplement P1.370
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 4, 2016.
Copyright & Usage: 
Copyright © 2016 by AAN Enterprises, Inc.

Author Disclosures

    1. Virginija Karrenbauer3,
    2. Jan Hillert1 and
    3. Ali Manouchehrinia2
  1. Virginija Karrenbauer3,
  2. Jan Hillert1 and
  3. Ali Manouchehrinia2
  1. 1Dep of Clinical Neuroscience K8 Karolinska Institute, Neurology R54 Stockholm Sweden
  2. 2Dep of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
  3. 3Dep of Clinical Neuroscience Karolinska institutet and Karolinska University Hospital Stockholm Sweden

Article usage

Article usage: April 2016 to June 2021

AbstractFullPdfSource
Apr 20162100Highwire
May 20161500Highwire
Jun 2016600Highwire
Jul 2016700Highwire
Aug 2016600Highwire
Sep 2016400Highwire
Oct 2016400Highwire
Nov 20162100Highwire
Dec 2016500Highwire
Jan 2017600Highwire
Feb 2017400Highwire
Mar 2017500Highwire
Apr 2017500Highwire
May 2017600Highwire
Jun 2017500Highwire
Jul 2017300Highwire
Aug 2017300Highwire
Sep 20171300Highwire
Nov 2017200Highwire
Dec 2017600Highwire
Jan 2018100Highwire
Mar 2018600Highwire
Apr 2018800Highwire
May 2018600Highwire
Jun 2018700Highwire
Jul 2018300Highwire
Aug 2018700Highwire
Sep 2018700Highwire
Oct 2018900Highwire
Nov 2018800Highwire
Dec 2018900Highwire
Jan 2019800Highwire
Feb 20192400Highwire
Mar 201910800Highwire
Apr 201913600Highwire
May 201911100Highwire
Jun 20197800Highwire
Jul 201915400Highwire
Aug 201926800Highwire
Sep 201927600Highwire
Oct 201926600Highwire
Nov 201918100Highwire
Dec 201910200Highwire
Jan 2020600Highwire
Feb 2020200Highwire
Apr 2020200Highwire
May 2020100Highwire
Jul 2020300Highwire
Aug 2020300Highwire
Sep 2020500Highwire
Oct 2020500Highwire
Nov 2020500Highwire
Dec 2020900Highwire
Jan 2021500Highwire
Feb 2021100Highwire
Mar 2021300Highwire
Apr 2021200Highwire
May 2021200Highwire
Jun 2021600Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me